SCHRODER INVESTMENT MANAGEMENT GROUP - SAREPTA THERAPEUTICS INC ownership

SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 459 filers reported holding SAREPTA THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 1.01 and the average weighting 0.2%.

Quarter-by-quarter ownership
SCHRODER INVESTMENT MANAGEMENT GROUP ownership history of SAREPTA THERAPEUTICS INC
ValueSharesWeighting
Q2 2024$5,887,238
+164.6%
37,261
+116.8%
0.01%
+100.0%
Q1 2024$2,224,900
-13.6%
17,186
-35.6%
0.00%0.0%
Q4 2023$2,574,681
+1807.2%
26,700
+1377.6%
0.00%
Q1 2021$135,000
-78.1%
1,807
-50.0%
0.00%
Q4 2020$616,000
+660.5%
3,614
+499.3%
0.00%
Q3 2020$81,000
-16.5%
6030.0%0.00%
Q2 2020$97,000
+155.3%
603
+61.2%
0.00%
Q1 2020$38,000
-79.1%
374
-68.9%
0.00%
Q2 2019$182,000
-34.1%
1,201
-48.2%
0.00%
Q1 2019$276,0002,3180.00%
Other shareholders
SAREPTA THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Asymmetry Capital Management, L.P. 87,180$2,581,0003.60%
Perceptive Advisors 1,771,029$52,422,0002.99%
SPHERA FUNDS MANAGEMENT LTD. 483,047$14,298,0002.80%
HealthCor Management, L.P. 1,550,000$45,880,0002.10%
Camber Capital Management LP 1,350,000$39,960,0001.62%
Tourbillon Capital Partners, L.P. 1,537,518$45,511,0001.17%
Elk Creek Partners, LLC 562,522$16,651,0001.02%
EMERALD ADVISERS, LLC 818,705$24,234,0001.00%
EMERALD MUTUAL FUND ADVISERS TRUST 604,467$17,892,0000.82%
Carlson Capital, L.P. 1,845,702$54,633,0000.70%
View complete list of SAREPTA THERAPEUTICS INC shareholders